| General Information of This Metabolic Reaction (MR) (ID:
MR006032) |
| Formula |
|
| Reactant |
Belinostat |
Product |
3-ASBA (3-Anilino-Sulfonyl Benzene Carboxylic Acid) |
|
Reactant Info
|
Product Info
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| References |
| 1 |
Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies
|
| 2 |
Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients. PLoS One. 2013;8(1):e54522.
|
| 3 |
In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.